These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 18537642)

  • 1. Ionotropic glutamate receptors & CNS disorders.
    Bowie D
    CNS Neurol Disord Drug Targets; 2008 Apr; 7(2):129-43. PubMed ID: 18537642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligands for ionotropic glutamate receptors.
    Swanson GT; Sakai R
    Prog Mol Subcell Biol; 2009; 46():123-57. PubMed ID: 19184587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
    Pittaluga A; Bonfanti A; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional stoichiometry of glutamate receptor desensitization.
    Bowie D; Lange GD
    J Neurosci; 2002 May; 22(9):3392-403. PubMed ID: 11978816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glutamate and its receptors in migraine.
    Vikelis M; Mitsikostas DD
    CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):251-7. PubMed ID: 17691981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glutamatergic neurotransmission in the striatum by presynaptic adenylyl cyclase-dependent processes.
    Dohovics R; Janáky R; Varga V; Hermann A; Saransaari P; Oja SS
    Neurochem Int; 2003 Jan; 42(1):1-7. PubMed ID: 12441162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
    Lees GJ
    Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of kainate receptors.
    Matute C
    CNS Neurosci Ther; 2011 Dec; 17(6):661-9. PubMed ID: 21129167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells.
    Morley P; Small DL; Murray CL; Mealing GA; Poulter MO; Durkin JP; Stanimirovic DB
    J Cereb Blood Flow Metab; 1998 Apr; 18(4):396-406. PubMed ID: 9538905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and dysregulation of neuronal circuits by KARs.
    Mulle C; Crépel V
    Neuropharmacology; 2021 Oct; 197():108699. PubMed ID: 34246686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective.
    Chałupnik P; Szymańska E
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ammonia effects on ionotropic glutamate receptors.
    Oja SS; Saransaari P
    Proc West Pharmacol Soc; 2000; 43():25-6. PubMed ID: 11056947
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
    Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
    Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentylenetetrazole-induced seizures affect binding site densities for GABA, glutamate and adenosine receptors in the rat brain.
    Cremer CM; Palomero-Gallagher N; Bidmon HJ; Schleicher A; Speckmann EJ; Zilles K
    Neuroscience; 2009 Sep; 163(1):490-9. PubMed ID: 19345722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of AMPA/kainate receptors during development of chick embryo retina cells: in vitro versus in vivo studies.
    Cristóvão AJ; Oliveira CR; Carvalho CM
    Int J Dev Neurosci; 2002 Feb; 20(1):1-9. PubMed ID: 12008069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia.
    Gao XM; Sakai K; Roberts RC; Conley RR; Dean B; Tamminga CA
    Am J Psychiatry; 2000 Jul; 157(7):1141-9. PubMed ID: 10873924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes.
    Sharp RL; May PC; Mayne NG; Snyder YM; Burnett JP
    Eur J Pharmacol; 1994 Jan; 266(1):R1-2. PubMed ID: 7511109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.